## SCHW: The Charles Schwab Corporation - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.9% in lower entry zone (3.0-6.0%), top 7% cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Strong momentum (+1.7% 5-day acceleration). Caution: overbought RSI (73).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($97.33)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Analysts Get Bullish on Charles Schwab (SCHW)**
- Source: Finviz | 20251221T160833 | Bullish | Relevance: 100%
- Analysts have recently shown a bullish outlook on The Charles Schwab Corporation (SCHW), with TD Cowen reiterating a Buy rating and UBS initiating coverage with a Buy rating and a positive price target. Both firms highlight Charles Schwab's market position, efficiency, and anticipated growth in earnings per share and operating margins, citing its potential for sustainable advantages and increased stock multiple. The company is expected to see significant improvements in fundamentals and aggressive strategic growth.

**2. Charles Schwab stock hits all-time high at 99.65 USD**
- Source: Investing.com | 20251222T144329 | Bullish | Relevance: 100%
- Charles Schwab Corp stock reached an all-time high of $99.65, driven by strong market performance, solid earnings, and strategic initiatives. The company reported a 34.61% 1-year return and maintained dividend payments for 37 consecutive years. Recent developments include increased core net new assets, enhancements to trading platforms, and a "Buy" rating from UBS.

**3. Analysts Get Bullish on Charles Schwab (SCHW)**
- Source: Insider Monkey | 20251221T094400 | Bullish | Relevance: 100%
- Analysts are showing a bullish outlook for The Charles Schwab Corporation (NYSE: SCHW), with TD Cowen reiterating a Buy rating and UBS initiating coverage with a Buy rating and setting a price target of $119. UBS highlights Schwab as a "premier player" with sustainable advantages due to its size and efficiency, forecasting a 48% jump in EPS for 2025 and projecting a 15% compound annual growth rate in EPS through 2028. The company is expected to see operating margin improvement and continued growth through product roadmaps and strategic M&A.

**4. The Charles Schwab Corporation (NYSE:SCHW) Receives Average Rating of "Moderate Buy" from Analysts**
- Source: MarketBeat | 20251221T062516 | Bullish | Relevance: 100%
- The Charles Schwab Corporation (NYSE:SCHW) has received a consensus "Moderate Buy" rating from 23 analysts, with an average 12-month price target of $108.37. The company is expanding into higher-margin offerings, including private market access and SOL futures for crypto trading, with analysts expecting a double-digit jump in Q4 2025 earnings. Despite recent insider stock sales, institutional ownership remains high at approximately 84.38%.

**5. Is It Too Late To Consider Charles Schwab After Its Strong 2025 Share Price Rally?**
- Source: Simply Wall Street | 20251220T233541 | Somewhat-Bullish | Relevance: 100%
- Charles Schwab (NYSE: SCHW) has seen a significant share price rally in 2025, up 33.8% year-to-date and 102.6% over five years. While the company's Excess Returns model suggests it is fairly valued, with an intrinsic value of about $92.40 per share, its Price-to-Earnings (PE) ratio indicates it might be somewhat overvalued compared to its fundamentals. The article encourages investors to use "Narratives" on Simply Wall St's Community page to personalize their valuation outlook based on different growth and risk scenarios.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $148 | $139 | +6% |
| 2025-12-12 | Barclays | $111 | $115 | -3% |
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.06M) |
| Sells | 16 ($14.65M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Heavy insider selling: $15M sold (16 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.67 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($14.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $184.1B |
| Beta | 0.96 |
| 52W Range | $65.88 - $101.74 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.67 |
| Forward P/E | 18.0 |
| Current P/E | 21.1 |
| YoY Growth | 17.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.2% to 3.9% (+1.7% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.66), confirming momentum. RSI overbought at 73, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.86% (CS: 93) | Strong |
| RSI_14 | 72.7 | Overbought |
| MACD Histogram | 0.66 | Bullish |
| vs SMA20 | 1.069x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.128x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $101.37
- **Stop Loss:** $97.33 (4.0% risk)
- **Target:** $107.43 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 222
- **Position Value:** $22,504.14
- **Portfolio %:** 22.50%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*